NCT06840977View on ClinicalTrials.gov

COLON ERDERLY LOW DOSE

Not yet recruitingOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Colon Adenocarcinoma
Trial Locations (1)

16128

E.O. Ospedali Galliera, Genoa

All Listed Sponsors
lead

Matteo Clavarezza

OTHER

NCT06840977 - COLON ERDERLY LOW DOSE | Biotech Hunter | Biotech Hunter